Detection of anthracycline-induced cardiotoxicity
- 31 August 1999
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 25 (4), 237-247
- https://doi.org/10.1053/ctrv.1999.0128
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Unbedenklichkeitsaspekte bei der Anwendung von pegyliertem liposomalem Doxorubicin bei KrebspatientenDrugs, 1997
- Iodine-123 metaiodobenzylguanidine in the assessment of late cardiac effects from cancer therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Assessing anthracycline cardiotoxicity in the 1990sEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Assessment of anthracycline-related myocardial adrenergic derangement by [123i]metaiodobenzylguanidine scintigraphyEuropean Journal of Cancer, 1995
- Detection of Early Anthracycline Cardiotoxicity by Monitoring the Peak Filling RateAmerican Journal of Clinical Oncology, 1993
- Electrocardiographic changes and arrhythmias after cancer therapy in children and young adultsThe American Journal of Cardiology, 1992
- Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy: Seven-year experience using serial radionuclide angiocardiographyAmerican Journal Of Medicine, 1987
- Clinical and morphologic cardiac findings after anthracycline chemotherapy: Analysis of 64 patients studied at necropsyThe American Journal of Cardiology, 1983
- Anthracycline cardiotoxicity: Clinical and pathologic outcomes assessed by radionuclide ejection fractionCancer, 1980
- Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide AngiocardiographyThe New England Journal of Medicine, 1979